Tong Ren Tang Technologies CoTGRNF 50 PB Ratio is 0.61 as of Jul. 03, 2026, which is 48% below its 10-year median of 1.18. GuruFocus rates TGRNF with a GF Score™ of 50/100 and a GF Value™ of $0.84 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 921 Drug Manufacturers companies, Tong Ren Tang Technologies Co ranks better than 91.31% on this metric.
Tong Ren Tang Technologies Co Ltd stock PB Ratio (=0.49) is close to 10-year low of 0.49.
The historical rank and industry rank for Tong Ren Tang Technologies Co's PB Ratio or its related term are showing as below:
TGRNF'
s PB Ratio Range Over the Past 10 Years
Min: 0.49 Med: 1.18 Max: 4.24
Current: 0.49
During the past 13 years, Tong Ren Tang Technologies Co's highest PB Ratio was 4.24. The lowest was 0.49. And the median was 1.18.
TGRNF's PB Ratio is ranked better than 91.31% of 921
companies
in the Drug Manufacturers industry
Industry Median: 1.91
vs TGRNF: 0.49
During the past 12 months, Tong Ren Tang Technologies Co's average Book Value Per Share Growth Rate was 5.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 3.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 3.10% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 5.40% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Tong Ren Tang Technologies Co was 88.90% per year. The lowest was 1.70% per year. And the median was 10.75% per year.
Back to Basics: PB Ratio
Tong Ren Tang Technologies Co (OTCPK:TGRNF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Tong Ren Tang Technologies Co PB Ratio Related Terms
Tong Ren Tang Technologies Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Tong Ren Tang Technologies Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tong Ren Tang Technologies Co PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Tong Ren Tang Technologies Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Tong Ren Tang Technologies Co's PB Ratio falls into.
Tong Ren Tang Technologies Co PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Tong Ren Tang Technologies Co (TGRNF) has a PB Ratio of 0.61 as of Jul. 03, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Tong Ren Tang Technologies Co and its competitors. This is 48% below median its historical median of 1.18. Over the past decade, Tong Ren Tang Technologies Co's PB Ratio has ranged from 0.49 to 4.24. According to the industry distribution chart, Tong Ren Tang Technologies Co ranks #80 out of 921 companies in the Drug Manufacturers industry, placing it in the top 8.7%.
Is Tong Ren Tang Technologies Co's PB Ratio too high?
Tong Ren Tang Technologies Co's current PB Ratio of 0.61 is 48% below median its 10-year median of 1.18. Over the past 10 years, this metric has ranged from a low of 0.49 to a high of 4.24. The Drug Manufacturers industry median PB Ratio is 1.91. Tong Ren Tang Technologies Co's value of 0.61 is 68.1% below this industry median. Based on the distribution chart, Tong Ren Tang Technologies Co ranks #80 out of 921 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Tong Ren Tang Technologies Co has a GF Score™ of 50/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tong Ren Tang Technologies Co's PB Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Tong Ren Tang Technologies Co ranks #80 out of 921 companies for PB Ratio. This places Tong Ren Tang Technologies Co in the top 9% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.91. Tong Ren Tang Technologies Co's value of 0.61 is 68.1% below this benchmark. Historically, Tong Ren Tang Technologies Co's own PB Ratio has ranged from 0.49 to 4.24 over the past decade. While the company's 10-year median is 1.18 vs. the industry median of 1.91, Tong Ren Tang Technologies Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.91, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tong Ren Tang Technologies Co's current PB Ratio of 0.61 is 68.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Tong Ren Tang Technologies Co and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tong Ren Tang Technologies Co's current PB Ratio is 0.61, which is 48% below median its own 10-year median of 1.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tong Ren Tang Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Tong Ren Tang Technologies Co (TGRNF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.84, compared to a current price of $0.49 — trading 41.1% below its estimated fair value. The current PB Ratio is 0.61, which is 48% below median its 10-year median of 1.18 and 68.1% below the Drug Manufacturers industry median of 1.91. Tong Ren Tang Technologies Co's overall GF Score™ is 50/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Tong Ren Tang Technologies Co (TGRNF), the current PB Ratio is 0.61 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tong Ren Tang Technologies Co (TGRNF) Overvalued in 2026?
Based on GuruFocus' analysis, Tong Ren Tang Technologies Co stock appears to be undervalued.
The current stock price of $0.49 is trading 41.1% below its estimated GF Value™ of $0.84.
GuruFocus considers Tong Ren Tang Technologies Co to be Significantly Undervalued.
Key valuation signals for TGRNF:
PB Ratio: 0.61 (48% below median its 10-year median of 1.18)
GF Value™: $0.84 vs. price of $0.49 (41.1% below fair value)
Industry Position: 68.1% below the Drug Manufacturers median (#80 of 921)
No single metric tells the full story. See the TGRNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tong Ren Tang Technologies Co Business Description
Tong Ren Tang Technologies Co Ltd is engaged in the production and distribution of Chinese medicine and predominantly operates in Mainland China and Hong Kong. The operating segments derive their revenue predominantly from the manufacture and sale of Chinese medicine of the company in Mainland China and Tong Ren Tang Chinese Medicine and its subsidiaries engaged in manufacturing, retail, and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments outside Mainland China and wholesale of healthcare products in Mainland China.
50GF Score
Get the complete analysis for TGRNF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TGRNF has been successfully added to your 
